Trial Profile
Trial to Determine the CR Rate at the Primary Tumor Site After 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, and 5-FU for Advanced Head and Neck Carcinoma Treated With Definitive Concurrent Cisplatin and Radiation Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Paclitaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 21 Aug 2020 Status changed from active, no longer recruiting to completed.
- 02 Jun 2015 Pooled preliminary analysis results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 06 Jan 2014 Status changed from suspended to active, no longer recruiting.